Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815591 | 12581559 | 1 | I | 20140616 | 20160712 | 20160721 | 20160721 | EXP | ES-BAXTER-2016BAX037610 | BAXTER | 70.92 | YR | M | Y | 0.00000 | 20160721 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815591 | 12581559 | 1 | PS | GENOXAL | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | U | 12142 | 1416 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 125815591 | 12581559 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | LAST DOSE RECEIVED ON 30SEP2014 | 0 | 150 | MG | QD | |||||||
| 125815591 | 12581559 | 3 | SS | vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | U | 0 | 2 | MG | ||||||||
| 125815591 | 12581559 | 4 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 15 | MG | QD | ||||||||
| 125815591 | 12581559 | 5 | C | ivabradine | IVABRADINE | 1 | Oral | 0 | 5 | MG | Q12H | ||||||||
| 125815591 | 12581559 | 6 | C | VALSARTAN HCTZ | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 80/12.5 MG | 0 | QD | |||||||||
| 125815591 | 12581559 | 7 | C | Manidipino | MANIDIPINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125815591 | 12581559 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125815591 | 12581559 | 9 | C | tiotropio bromuro de | 2 | Respiratory (inhalation) | 0 | 18 | UG | QD | |||||||||
| 125815591 | 12581559 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125815591 | 12581559 | 1 | Lymphoma |
| 125815591 | 12581559 | 2 | Non-small cell lung cancer |
| 125815591 | 12581559 | 3 | Lymphoma |
| 125815591 | 12581559 | 4 | Lymphoma |
| 125815591 | 12581559 | 5 | Atrial flutter |
| 125815591 | 12581559 | 6 | Product used for unknown indication |
| 125815591 | 12581559 | 7 | Hypertension |
| 125815591 | 12581559 | 8 | Hypertension |
| 125815591 | 12581559 | 9 | Product used for unknown indication |
| 125815591 | 12581559 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125815591 | 12581559 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125815591 | 12581559 | Cough | |
| 125815591 | 12581559 | Febrile neutropenia | |
| 125815591 | 12581559 | Odynophagia | |
| 125815591 | 12581559 | Pulmonary sepsis | |
| 125815591 | 12581559 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125815591 | 12581559 | 1 | 20140402 | 20140730 | 0 | |
| 125815591 | 12581559 | 2 | 20140610 | 20140930 | 0 | |
| 125815591 | 12581559 | 3 | 20140402 | 20140730 | 0 |